Cardiac resynchronization therapy for heart failure: A hammer in search of nails

Circulation

Volumn 118, Issue 9, 2008, Pages 901-903

  McAlister, Finlay A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE;

ANGIOCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAM; FOLLOW UP; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HYPERKALEMIA; IMPLANTATION; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; COMORBIDITY; HEART PACING; HUMAN; NOTE; RANDOMIZED CONTROLLED TRIAL;

CARDIAC PACING, ARTIFICIAL; COMORBIDITY; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 52049109223     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.800722     Document Type: Editorial

References (19)

1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Dryden DM, Spooner C, Page RL, Hlatky M, Rowe BH. The role of cardiac resynchronization therapy in patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502-2514.
2. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008;23(suppl 1):13-19.
3. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC, for the Get With the Guidelines Steering Committee and Hospitals. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation. 2008;118:926-933.
4. Kaul P, Peterson ED. The cardiovascular world is definitely not flat. Circulation. 2007;115:158-160.
5. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146:250-257.
6. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240-1247.
7. Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21:559-563.
8. McAlister FA, Tu JV, Newman A, Lee D, Kimber S, Cujec B, Armstrong PW. How many patients with heart failure are eligible for cardiac resynchronization? Insights from 2 prospective cohorts. Eur Heart J. 2006;27: 323-329.
9. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, Sandberg KR, McCullough PA. Congestive heart failure and QRS duration. Establishing prognosis study. Chest. 2002;122:528-534.
10. Lenfant C. Clinical research to clinical practice: lost in translation? N Engl J Med. 2003;349:868-874.
11. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021-1026.
12. McAlister FA. Applying evidence to patient care: from black and white to shades of grey. Ann Intern Med. 2003;138:938-939.
13. Pitt B, Zannad F, Remme WJ, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717.
14. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351:543-551.
15. Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation. 2005;112:39-47.
16. Singh SM, Austin PC, Chong A, Alter DA. Coronary angiography following acute myocardial infarction in Ontario, Canada. Arch Intern Med. 2007;167:808-813.
17. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation. 2006;113:374-379.
18. Leff B, Finucane TE. Gizmo idolatry. JAMA. 2008;299:1830-1832.
19. Omoigui NA, Silver MJ, Rybicki LA, Rosenthal M, Berdan LG, Pieper K, King SV, Califf RM, Topol EJ. Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol. 1998;31:265-272.